Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Interest Receivables (2023 - 2025)

iBio (IBIO) has disclosed Change in Interest Receivables for 3 consecutive years, with $20000.0 as the latest value for Q4 2025.

  • Quarterly Change in Interest Receivables rose 42.86% to $20000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68000.0 through Dec 2025, down 11.69% year-over-year, with the annual reading at $62000.0 for FY2025, 29.55% down from the prior year.
  • Change in Interest Receivables for Q4 2025 was $20000.0 at iBio, up from $19000.0 in the prior quarter.
  • The five-year high for Change in Interest Receivables was $22000.0 in Q3 2023, with the low at $14000.0 in Q4 2024.
  • Average Change in Interest Receivables over 3 years is $18900.0, with a median of $19500.0 recorded in 2024.
  • The sharpest move saw Change in Interest Receivables crashed 36.36% in 2024, then skyrocketed 42.86% in 2025.
  • Over 3 years, Change in Interest Receivables stood at $22000.0 in 2023, then plummeted by 36.36% to $14000.0 in 2024, then surged by 42.86% to $20000.0 in 2025.
  • According to Business Quant data, Change in Interest Receivables over the past three periods came in at $20000.0, $19000.0, and $15000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.